| Keyword search (4,163 papers available) | ![]() |
"Daskalopoulou SS" Authored Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | The age of obesity onset affects changes in subcutaneous adipose tissue macrophages and T cells after weight loss | Murphy J; Morais JA; Tsoukas MA; Cooke AB; Daskalopoulou SS; Santosa S; | 40831565 SOH |
| 2 | Age of obesity onset affects subcutaneous adipose tissue cellularity differently in the abdominal and femoral region | Murphy J; Dera A; Morais JA; Tsoukas MA; Khor N; Sazonova T; Almeida LG; Cooke AB; Daskalopoulou SS; Tam BT; Santosa S; | 39045668 SOH |
| 3 | Methodological considerations for the measurement of arterial stiffness using applanation tonometry | Cooke AB; Kuate Defo A; Dasgupta K; Papaioannou TG; Lee J; Morin SN; Murphy J; Santosa S; Daskalopoulou SS; | 33031179 PERFORM |
| 4 | Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. | Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Laroc | 27118291 HKAP |
| 5 | Neighbourhood walkability and home neighbourhood-based physical activity: an observational study of adults with type 2 diabetes. | Hajna S, Kestens Y, Daskalopoulou SS, Joseph L, Thierry B, Sherman M, Trudeau L, Rabasa-Lhoret R, Meissner L, Bacon SL, Gauvin L, Ross NA, Dasgupta K, Diabetes, GPS, and Walkablilty Study Group | 27613233 HKAP |
| 6 | Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome. | Pelletier R, Choi J, Winters N, Eisenberg MJ, Bacon SL, Cox J, Daskalopoulou SS, Lavoie KL, Karp I, Shimony A, So D, Thanassoulis G, Pilote L, GENESIS-PRAXY Investigators | 27683172 HKAP |
| 7 | Physician step prescription and monitoring to improve ARTERial health (SMARTER): A randomized controlled trial in patients with type 2 diabetes and hypertension. | Dasgupta K, Rosenberg E, Joseph L, Cooke AB, Trudeau L, Bacon SL, Chan D, Sherman M, Rabasa-Lhoret R, Daskalopoulou SS, SMARTER Trial Group | 28074635 HKAP |
| 8 | Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. | Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell | 28449828 HKAP |
| 9 | Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. | Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP | 30301743 HKAP |
| Title: | Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. | ||||
| Authors: | Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell | ||||
| Link: | https://www.ncbi.nlm.nih.gov/pubmed/28449828?dopt=Abstract | ||||
| Publication: | |||||
| Keywords: | |||||
| PMID: | 28449828 | Category: | Can J Cardiol | Date Added: | 2019-05-31 |
| Dept Affiliation: |
HKAP
1 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: aacleung@ucalgary.ca. 2 Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Quebec, Canada. 3 Departments of Family Medicine and Community Health Sciences, Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 4 Departments of Medicine and Community Health Sciences, Libin Cardiovascular Institute of Alberta, O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada. 5 Division of General Internal Medicine, University of Calgary, Calgary, Alberta, Canada. 6 Department of Medicine and Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada. 7 Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. 8 Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada. 9 Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada. 10 Department of Family Medicine, University of British Columbia, Copeman Healthcare Centre, Vancouver, British Columbia, Canada. 11 Institut de Recherches Cliniques de Montréal, Université de Montréal, Montréal, Quebec, Canada. 12 Department of Medicine, Université Laval, Québec, Quebec, Canada. 13 McMaster University, Hamilton, Ontario, Canada. 14 CHU-Québec-Hopital St Sacrement, Québec, Quebec, Canada. 15 University of Alberta, Edmonton, Alberta, Canada. 16 University of Toronto, Toronto, Ontario, Canada. 17 Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada. 18 Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Quebec, Canada. 19 Department of Medicine, Division of Clinical Pharmacology, Western University, London, Ontario, Canada. 20 Discipline of Medicine, Memorial University of Newfoundland, St John's, Newfoundland and Labrador. 21 Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada. 22 University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 23 Department of Medicine and Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. 24 Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. 25 University Health Network, University of Toronto, Toronto, Ontario, Canada. 26 Departments of Medicine (Division of Endocrinology) and Biochemistry, Western University, London, Ontario, Canada. 27 Vancouver Coastal Health Addiction Services, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 28 Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 29 Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 30 Department of Medicine, University of Calgary, Calgary, Alberta, Canada. 31 Department of Exercise Science, Concordia University, and Montreal Behavioural Medicine Centre, Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS-NIM), Hôpital du Sacré-Coeur de Mont |
||||
Description: |
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017 05;33(5):557-576 Authors: Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM, Hypertension Canada Abstract PMID: 28449828 [PubMed - indexed for MEDLINE] |



